>>> US Research Calls

Research Calls I
  • Upgrades:
    • Arcturus Therapeutics (ARCT) upgraded to Buy from Neutral at Citigroup, tgt $20
    • Americold Realty Trust (COLD) upgraded to Neutral from Underweight at JPMorgan, tgt $16
    • CoreWeave (CRWV) upgraded to Overweight from Neutral at JPMorgan, tgt $125
    • Dollar General (DG) upgraded to Buy from Hold at HSBC, tgt $160
    • EastGroup Properties (EGP) upgraded to Overweight from Neutral at JPMorgan, tgt $231
    • Macerich (MAC) upgraded to Overweight from Neutral at JPMorgan, tgt $26
    • Nebius Group (NBIS) upgraded to Outperform from Neutral at BNP Paribas Exane, tgt $399
    • Paychex (PAYX) upgraded to Neutral from Underweight at JPMorgan, tgt $115
    • Quanta Services (PWR) upgraded to Outperform from Market Perform at Bernstein, tgt $775
    • Welltower (WELL) upgraded to Overweight from Neutral at JPMorgan, tgt $260
  • Downgrades:
    • Alexandria Real Estate (ARE) downgraded to Underweight from Neutral at JPMorgan, tgt $56
    • Alkami Technology (ALKT) downgraded to Underweight from Overweight at JPMorgan, tgt $14
    • Bayerische Motoren Werke (BMWYY) downgraded to Hold from Buy at HSBC
    • Dropbox (DBX) downgraded to Sell from Neutral at Citigroup, tgt $29
    • Etsy (ETSY) downgraded to Neutral from Buy at Arete, tgt $81
    • Gaming and Leisure Properties (GLPI) downgraded to Neutral from Overweight at JPMorgan, tgt $46
    • Kite Realty Group (KRG) downgraded to Underweight from Neutral at JPMorgan, tgt $27
    • Rollins (ROL) downgraded to Neutral from Overweight at Piper Sandler, tgt $33
    • Safehold (SAFE) downgraded to Underweight from Neutral at JPMorgan, tgt $14
    • Stitch Fix (SFIX) downgraded to Market Perform from Outperform at William Blair
    • Tanger Factory Outlet Centers (SKT) downgraded to Neutral from Overweight at JPMorgan, tgt $39
    • VICI Properties (VICI) downgraded to Neutral from Overweight at JPMorgan, tgt $30
  • Others:
    • AbCellera (ABCL) resumed with a Neutral at Goldman, tgt $13
    • Ares Management (ARES) initiated with an Overweight at Piper Sandler, tgt $150
    • Arrowhead Pharmaceuticals (ARWR) resumed with a Neutral at Goldman, tgt $74
    • Avidbank Holdings (AVBH) initiated with a Buy at StoneX,t gt $40
    • BayCom (BCML) initiated with a Buy at StoneX
    • BlueLinx (BXC) initiated with a Market Perform at Citizens
    • CNB Financial (CCNE) initiated with an Overweight at Piper Sandler, tgt $38
    • The Carlyle Group (CG) initiated with an Overweight at Piper Sandler, tgt $54
    • Contineum Therapeutics (CTNM) resumed with an Early-Stage Biotech rating at Goldman
    • Community West Bancshares (CWBC) initiated with a Buy at StoneX, tgt $30
    • Energy Services of America (ESOA) initiated with a Buy at Roth Capital, tgt $20
    • Enterprise Financial Services (EFSC) initiated with a Buy at StoneX, tgt $70
    • Eupraxia Pharmaceuticals (EPRX) initiated with an Outperform at Wedbush, tgt $17
    • Fervo Energy (FRVO) initiated with a Buy at Johnson Rice, tgt $35
    • First Interstate Bancsystems (FIBK) initiated with a Hold at StoneX
    • FuelCell Energy (FCEL) initiated with an Equal Weight at Barclays, tgt $20
    • Hope Bancorp (HOPE) initiated with a Hold at StoneX
    • Imax (IMAX) initiated with an Overweight at Morgan Stanley, tgt $63
    • Insmed (INSM) resumed with a Buy at Goldman, tgt $188
    • Iovance Biotherapeutics (IOVA) resumed with a Buy at Goldman, tgt $15
    • Jazz Pharmaceuticals (JAZZ) resumed with a Buy at Goldman, tgt $337
    • Kodiak Sciences (KOD) resumed with a Neutral at Goldman, tgt $36
    • Krystal Biotech (KRYS) resumed with a Buy at Goldman, tgt $441
    • Kymera Therapeutics (KYMR) resumed with an Early-Stage Biotech rating at Goldman
    • Madrigal Pharmaceuticals (MDGL) resumed with a Buy at Goldman, tgt $704
    • MeiraGTx Holdings (MGTX) initiated with a Neutral at Goldman, tgt $16
    • MGE Energy (MGEE) initiated with a Neutral at BofA Securities, tgt $76
    • MGM Resorts (MGM) resumed with a Neutral at BofA Securities, tgt $40
    • MiniMed Group (MMED) initiated with a Buy at Truist Securities, tgt $29
    • NeOnc Technologies (NTHI) initiated with a Buy at Roth Capital, tgt $20
    • Old National Bancorp (ONB) initiated with an Overweight at Wells Fargo, tgt $30
    • Preferred Bank (PFBC) initiated with a Buy at StoneX, tgt $120
    • PubMatic (PUBM) initiated with a Buy at Craig-Hallum, tgt $24
    • Quince Therapeutics (QNCX) initiated with a Buy at Rodman & Renshaw, tgt $70
    • Revolution Medicines (RVMD) resumed with a Buy at Goldman, tgt $267
    • Sagimet Biosciences (SGMT) resumed with a Sell at Goldman, tgt $7
    • Southern Missouri Bancorp (SMBC) initiated with a Buy at StoneX, tgt $80
    • Tarsus Pharmaceuticals (TARS) resumed with a Buy at Goldman, tgt $116
    • Turn Therapeutics (TTRX) initiated with a Buy at Lucid Capital Markets, tgt $24
    • United Therapeutics (UTHR) initiated with a Sell at Goldman, tgt $321
    • Versant Media Group (VSNT) initiated with a Buy at Citigroup,t gt $41
    • Wintrust Financial (WTFC) initiated with an Equal Weight at Wells Fargo, tgt $160